What is the RESPONSIBLE way to handle peptides? There are no randomized controlled trials, no established dose for many of these unapproved peptides. They may be exciting and have promise, but we BPC 157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers FDA considers adding a dozen peptides to its bulk drug compounding list RAPS RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals